Roche will publish its Sales Results for the 1st Quarter 2025 prior to the opening of the Swiss Stock Exchange on Thursday, 24 April 2025.




07:00 CEST / 06:00 BST / 01:00 AM EDT / 10:00 PM PDT (evening before)

Release will be e-mailed and posted on the Roche IR website > click here
Presentation slides will be posted on the Roche IR website > click here




14:00 – 15:30 CEST / 13:00 – 14:30 BST
08:00 – 09:30 AM EDT / 05:00 - 06:30 AM PDT
The webinar will start with presentations by senior management, followed by a Q&A session.

Presenters:

  • Thomas Schinecker, CEO Roche Group
  • Alan Hippe, Chief Financial Officer
  • Teresa Graham, CEO Roche Pharmaceuticals
  • Matt Sause, CEO Roche Diagnostics 



We would like to invite all interested parties to participate in the webinar and to pre-register for the event here.*

Should you be unable to register for the webinar due to your company IT policy, please send an e-mail to investor.relations@roche.com.




A replay of the webcast will be available via > ir.roche.com
*privacy notice




Best regards,





Bruno Eschli
Head of Investor Relations


 
Roche Investor Relations 
Dr. Bruno Eschli
Phone: +41 61 68-75284
e-mail: bruno.eschli@roche.com


Dr. Sabine Borngräber
Phone: +41 61 68-88027
e-mail: sabine.borngraeber@roche.com


Dr. Birgit Masjost
Phone: +41 61 68-84814
e-mail: birgit.masjost@roche.com


 
  
Investor Relations North America 
Loren Kalm
Phone: +1 650 225 3217
e-mail: kalm.loren@gene.com		 

Get the latest news and updates to your inbox.